Mwyngil Therapeutics Inc.
PrivateLast Round
Seed
May 27, 2022
Company Overview
Mwyngil Therapeutics Inc. is a biopharmaceutical company that develops small-molecule therapies for cardiovascular, metabolic, and chronic inflammatory and immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mwyngil Therapeutics Inc. Comparables
Compare Mwyngil Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novo Nordisk | 80% | |
| NodThera | 78% | |
| Brenig Therapeutics | 76% |
Mwyngil Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2022 |
Mwyngil Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| Torrey Pines Investment LLC | Seed |
| i2020 Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2022
Seed round raised with OrbiMed and Torrey Pines Investment LLC.
Recent news
Latest coverage and updates
- is_developingJun 25, 2026
Mwyngil Inc. is developing first-in-class oral small molecule therapies on Jun 25th '26.
Mwyngil Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mwyngil Therapeutics Inc.'s valuation, stock price, and market status.
Is Mwyngil Therapeutics Inc. a public or private company?
Mwyngil Therapeutics Inc. is a private company.
What is the current stock price of Mwyngil Therapeutics Inc.?
Mwyngil Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Mwyngil Therapeutics Inc. worth (valuation)?
Valuation information for Mwyngil Therapeutics Inc. is not publicly available.
Can I buy Mwyngil Therapeutics Inc. stock?
Mwyngil Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mwyngil Therapeutics Inc.'s last funding round?
Mwyngil Therapeutics Inc.'s most recent funding round was Seed on May 27, 2022.
Who are the main investors in Mwyngil Therapeutics Inc.?
Key investors in Mwyngil Therapeutics Inc. include OrbiMed, Torrey Pines Investment LLC, i2020 Accelerator.
Will Mwyngil Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Mwyngil Therapeutics Inc..
How can I track Mwyngil Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mwyngil Therapeutics Inc.'s secondary market activity and sign up for updates.